VMI
VHCP Management III Portfolio holdings
AUM
$504M
This Quarter Return
+61.32%
1 Year Return
+678.37%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$172M
AUM Growth
+$172M
(+25%)
Cap. Flow
+$6.59M
Cap. Flow
% of AUM
3.84%
Top 10 Holdings %
Top 10 Hldgs %
92.24%
Holding
17
New
2
Increased
2
Reduced
4
Closed
1
Top Buys
1 |
Axsome Therapeutics
AXSM
|
$15.2M |
2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$6.45M |
3 |
Protagonist Therapeutics
PTGX
|
$4.85M |
4 |
BLPH
Bellerophon Therapeutics, Inc.
BLPH
|
$93.3K |
Top Sells
1 |
KalVista Pharmaceuticals
KALV
|
$9M |
2 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$4.12M |
3 |
DBVT
DBV Technologies
DBVT
|
$4.09M |
4 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$2.64M |
5 |
KA
Kineta, Inc. Common Stock
KA
|
$158K |
Sector Composition
1 | Healthcare | 96.01% |